Perspectives on Germline Gene Editing Regulation: An ASHG Forum
Recorded On: 10/17/2019
- Regular Member - Free!
- Early Career Member - Free!
- Resident/Clinical Fellow Member - Free!
- Postdoctoral Fellow Member - Free!
- Graduate Student Member - Free!
- Undergraduate Student Member - Free!
- Emeritus Member - Free!
- Life Member - Free!
- Trainee Member - Free!
- Nonmember - Free!
As reflected in ASHG's 2017 statement, there are a number of challenges and issues associated with germline genome editing, and the global scientific community has organized to guide decision-making, regulation, and governance of its future application. In particular, the National Academies of Sciences, Engineering, and Medicine and the Royal Society recently launched an international commission on this topic; similarly, the World Health Organization has established an advisory committee. This 90-minute forum convened by ASHG will be an opportunity for attendees to hear from and engage with leaders on these international panels on an appropriate framework for the appropriate use of germline genome editing.
Moderator: Charles Rotimi, PhD, Director, Center for Research on Genomics and Global Health at NIH